FDA’s Rejection of MDMA Psychotherapy for Trauma Draws Criticism from Psychedelic Experts

FDA rejected MDMA-assisted PTSD therapy. Other psychedelics firms intend to avoid that fate

The FDA Just Rejected a Bid for MDMA to Treat PTSD

FDA approves drug targeting Johns Hopkins-discovered brain cancer gene mutation - EurekAlert